The calcitonin (CT)/calcitonin gene-related peptide I (CGRP-I) gene (CALC-I gene) is subject to alternative tissue-specific processing of its primary transcript. CT mRNA is the predominant mRNA produced in thyroid C cells, whereas CT gene-related peptide I mRNA is the main product in neurons of the central and peripheral nervous systems. The CT-specific exon 4 is surrounded by weak processing sites. In this study we have investigated whether exon 4 sequences are involved in the tissue-specific selection of the exon 4 splice acceptor site. The results indicate that two separate elements, termed A and B, in the 5' part of exon 4 are required for production of CT-specific RNA. These sequences are located between nucleotides 67 and 88 (A) and nucleotides 117 and 146 (B) relative to the 5' end of exon 4. Variation of the distance between these sequence elements and the 3' splice site of exon 4 does not change the processing choice. These sequence elements are functionally equivalent. CT-specific splicing requires the presence of both sequence A and B or duplicates of either sequence element in exon 4. The effect of these sequences on the RNA processing choice is overruled by mutation of the CT-specific uridine branch acceptor nucleotide into a commonly preferred adenosine residue.
Alternative splicing of mRNA precursors is an important mechanism in regulation of gene expression (for reviews, see references 40 and 41) . The differential incorporation of exons into mature mRNA is often under tissue-specific or developmental control. Progress has been made towards understanding the biochemistry of pre-mRNA splicing (for a review, see reference 30) . However, the mechanism by which the splicing machinery selects the correct pairs of splice sites as well as identification of cis-and trans-acting factors involved in tissue-specific or developmentally regulated RNA processing is still a major issue in splicing research.
The alternative processing of the human calcitonin (CT)/ calcitonin gene-related peptide I (CGRP-I) pre-mRNA (CALC-I pre-mRNA) results in cell-type-specific expression of two different proteins. The CT mRNA is generated in thyroid C cells by splicing of the three most 5' exons to the CT-encoding exon 4. The poly(A) site at the end of exon 4 is used in this RNA. CGRP-I mRNA results from splicing of the first three common exons to exon 5 and the polyadenylated exon 6 in particular neural cells (5, 22, 49, 54) .
We have previously studied the alternative processing of a minigene, containing the exon 3 to exon 5 region of the human CALC-I gene both in vivo (4) and in vitro (7, 8) . Analysis of the branchpoint used in the splicing of exon 3 to exon 4 showed that a uridine residue is used as the major branch acceptor nucleotide (3) . Mutation of this unusual uridine branch acceptor nucleotide into a commonly preferred adenosine residue results in an increase in CT-specific splicing efficiency in nonneural 293 cells (4) and in the predominant production of CT mRNA in otherwise CGRP-I-producing F9 cells (1) . Replacement of the weak exon 4 poly(A) site with stronger poly(A) sites also results in an increase in CT-specific processing (59) . The presence of weak processing sites at both ends of the CT-specific exon 4 may be a prerequisite for the proper regulation of alternative processing of the CALC-I pre-mRNA.
cis-acting elements involved in alternative processing are often located in the processing signals. However, sequences located within exons can also influence the processing choice of alternatively processed pre-mRNAs both negatively or positively. In vivo and in vitro experiments performed on a large number of genes have indicated a role for exon sequences in splice site selection (15, 16, 21, 27, 31, 32, 36, 38, 43, 46, 55, 58, 60, 62) . With the exception of Drosophila doublesex pre-mRNA and the Drosophila P element, the role of exon sequences in splice site selection remains unclear. Two trans-acting factors, transformer and transformer-2 bind to regulatory elements in the femalespecific exon of the doublesex pre-mRNA, thereby promoting spliceosome formation (33, 50, 57) . The somatic inhibition of Drosophila P-element third intron splicing involves RNA-protein complexes bound to an exon pseudo-5' splice site (11, 51) . This complex interferes with binding of Ul small nuclear ribonucleoprotein (RNP) to the authentic 5' splice site. In several other cases, mutations in exon sequences may result in a change in the secondary structure of the pre-mRNA, which either sequesters or exposes the splice sites (21, 36) .
In this study we have investigated the involvement of exon 4 sequences in the alternative RNA processing of the human CALC-I gene. Transfection studies with several deletion and substitution mutants show that specific exon 4 sequences are required for CT-specific processing.
GATGXCAICCAAGTCGCTGGACATATCC3'. These primers were used in combination with an oligonucleotide complementary to part of the multiple cloning (MC) site (HindIII primer, 5'CACCTCCAAfL(lCGACTC3'). The underlined HindIII and NsiI restriction sites were used for cloning the PCR fragments into the HindIII and NsiI sites of pRSV dI3 (Fig. 1) . pRSV dI3E4(251-443) was constructed by using fragments made by PCR with the exon 4 primer E4(251), 5'TAATCGATGCATTGTCCTGCTTCTGAATGTGC3', and the intron 4 primer, 5'TGTCCAGCcTAGCCTAGGGT3'.
The underlined NsiI and NheI sites were used for cloning the PCR fragment into the NsiI and NheI sites of pRSV dI3. The CALC-I minigenes with the branch acceptor nucleotide mutation pRSV dI3E4(50-251)U-A and pRSV dI3E4(152-251)U-A were made by PCR on pRSV dI3(U-A). pRSV dE4(50-251) and pRSV dE4(152-251) were made by cloning the NcoI fragments of pRSV dI3E4(50-251) and pRSV dI3E4(152-251) into the NcoI sites of pRSV WT. pCTS9 was made by cloning the SalI-NsiI fragment (the SalI restriction site is located in the multiple cloning site in front of exon 3) of pRSV WT in the BssHII-NsiI sites of pG4hCT9, which contains the complete CALC-I gene, including its own promoter (1). The SalI and BssHII sites were made blunt ended by using the Klenow enzyme. Because of cloning procedures, pCTS9 contains 24 additional nucleotides (nt) in exon 3. pCTS9 dE4(50-251) and pCTS9 dE4(152-251) were made by inserting the SalI-NsiI fragments of pRSV dE4(50-251) and pRSV dE4(152-251) into the BssHII-NsiI sites of pG4hCT9.
The positions of the other exon 4 deletions in pRSV dI3 are indicated in Fig. 1 . pRSV dI3E4(117-146) was constructed using fragments made by PCR with the primers HindIII; E4(117), 5 before (4) . For 5 ). The observed CT/CGRP ratio after RT-PCR amplification was in agreement with the input ratio of the RNAs. The ratio of CT to CGRP spliced products did not change significantly by varying the number of PCR cycles, and only small variations were observed with different primer combinations (1).
RESULTS
The presence or absence of specific exon sequences can determine the RNA processing choice of alternatively processed pre-mRNAs (15, 16, 21, 27, 31, 32, 36, 38, 43, 46, 55, 58, 60, 62) . We have investigated the influence of exon 4 sequences on the processing choice of the CALC-I premRNA. Transient transfection of a minigene (pRSV WT) containing the exon 3 to exon 5 region of the human CALC-I gene to 293 cells results in the predominant production of CT-specific RNA (CT RNA) (4) (Fig. 2, lane 1) . After transfection, RNA was isolated and analyzed in an RT-PCR analysis with an exon 4 and an exon 5 primer for the RT reaction and addition of the RSV primer for the subsequent PCR reaction. The PCR products were analyzed on a Southern blot by hybridization to an exon 3-specific probe. Introduction of a large deletion (+860 nt) in intron 3 (pRSV dI3 (2) . Symbols are as in Fig. 2. due to removal of specific exon 4 sequences or to the decreased size of exon 4. However, the length of both the 5' end and the 3' end deletions are very similar. Therefore, we conclude that specific sequences in the 5' part of exon 4 are required for the CT-specific processing after transient transfection of the CALC-I minigene to 293 cells.
Two regions in exon 4 are involved in CT-specific processing of the CALC-I pre-mRNA. We have further characterized the sequences involved in CT-specific processing of the human CALC-I pre-mRNA by construction of small deletions in the 5' part of exon 4 as listed in Fig. 1 (Fig. 3, lane 1) . We therefore concluded that the cis-acting sequences are located in the 5' part of exon 4, upstream of nt 152. Our further exon 4 deletions are located within this region. Transfection of plasmids pRSV dI3E4 or pRSV dI3E4(35-68), of which the deletions are located most 5' in exon 4, results in CT-specific processing (Fig. 3, lanes 2 and 3) . In contrast, after transfection of plasmids pRSV dI3E4(63-101) or pRSV dI3E4(117-146), both CT RNA and CGRP RNA could be detected (Fig. 3, lanes 6 and 7) . cis-acting sequences are located in both removed regions. The deleted sequences could be part of a single cis-acting element or consist of separate elements. Deletion of a sequence element which resides between these two deletions as in pRSV dI3E4(87-114), however, does not result in an increase in the CGRP/CT ratio. Transfection of this construct results in the production of only CT RNA (Fig. 3, lane 5 ). Since the deletion in pRSV dI3E4(87-114) partially overlaps the deletion of pRSV dI3E4 , these data imply that the actual cis-acting region is located between nt 63 and 88, as was shown with plasmid pRSV dI3E4 (Fig. 2, lane 5) , whereas the smaller deletions from nt 63 to 88, 63 to 101, or 117 to 146 result in the production of both CGRP RNA and CT RNA (Fig. 3, lanes  4, 6, and 7) . The effect of both deletions on the RNA processing choice may therefore be additive. Larger deletions were made to investigate the additive effect of both deletions. In pRSV dI3E4(63-114) and pRSV dI3E4(87-146), the size of the deleted fragment was increased compared with the former deletions, but they still contain only one of the cis-acting elements. Transfection of these plasmids results in the formation of both CT RNA and CGRP RNA, as after transfection of their corresponding smaller deletions (Fig. 3, lanes 8 and 9) . A slight increase in the CGRP/CT ratio was observed after transfection of pRSV dI3E4(87-146) compared with pRSV dI3E4(117-146). Slight variations of the CGRP/CT ratio were also observed in different transfection experiments. In pRSV dI3E4(63-146), the exon 4 deletion included both regions. The CGRP/CT ratio observed after transfection of this plasmid to 293 cells was increased compared with the ratio after transfection of plasmids containing deletions of one of the individual elements. Only minor amounts of CT RNA could be observed (Fig. 3, lane  10) . We conclude that both regions cooperate to promote CT-specific processing in 293 cells. The effect of deletion of these regions on the RNA processing choice is additive.
The two regions are functionally equivalent. Deletion of specific regions of exon 4 results in an increase in CGRP-Ispecific splicing. This could be due to a change in secondary structure of the RNA or to the removal of specific sequences required for binding of factors which stimulate CT-specific processing. We have excluded the possibility that the effect is simply due to the decrease in length of exon 4.
To investigate whether reinsertion of the deleted sequences could restore the exclusive production of CT RNA, we made several insertion mutants. Oligonucleotides were inserted into the XhoI sites which were created in exon 4 during the construction of the deletions (Materials and Methods). The sequences of the oligonucleotides used for the insertion mutants are shown in Fig. 1B Fig. 4 (lanes 2 and 5) . Both insertion mutants produced predominantly CT RNA, which was expected since the deleted fragments were reinserted at almost their original positions. We also investigated whether element A could substitute for element B and vice versa. Oligonucleotide A was inserted in the XhoI site of pRSV dI3E4(117-146), and oligonucleotide B was inserted in the XhoI site of pRSV dI3E4(63-101) to produce pRSV dI3E4(117-146)A and pRSV dI3E4(63-101)B, respectively. In the resulting plasmids, element A or element B is present twice. The CGRP/CT ratios observed after transfection of plasmids pRSV dI3E4(63-101)A, pRSV dI3E4(63-101)B, pRSV dI3E4(117-146)B, and pRSV dI3E4(117-146)A are very similar (Fig. 4, lanes 2, 3, 5 , and 6). Only very low amounts of CGRP RNA could be detected. Therefore, element A can replace element B and vice versa (further evidence is shown in Fig. 5 ).
Function of sequence elements required for CT-specific splicing is not dependent on the distance to the 3' splice site of exon 4. The nucleotide sequences of oligonucleotide A and oligonucleotide B are completely different (Fig. 1B) . Insertion of oligonucleotide A or B would therefore induce different secondary structures. Insertion of oligonucleotide A or B in pRSV dI3E4(63-101) or in pRSV dI3E4(117-146) results in an increase in CT-specific processing. These results suggest that the sequence elements A and B have a stimulatory effect on CT-specific spliceosome formation. To investigate the possible role of the distance between the putative target sequences and the 3' splice site of exon 4 on the processing choice, we inserted the oligonucleotides in different contexts and analyzed the processing products.
In pRSV dI3E4(63-101)A and pRSV dI3E4(87-114), fragment A and B are already slightly closer to each other than they are in the authentic exon 4. In oligonucleotide AB, the sequences of element A and of element B are directly next to each other. This oligonucleotide AB was cloned into the XhoI site of pRSV dI3E4(63-146), which produces predominantly CGRP RNA, and the resulting plasmid pRSV dI3E4(63-146)AB was transfected to 293 cells. As shown in Fig. 4 (lane 8), exclusively CT RNA is produced. This indicates that the distance between both sequence elements can be varied without changing the RNA processing choice.
Several other large deletions in addition to pRSV dI3E4(63-146) have been constructed. pRSV dI3E4 and pRSV dI3E4(13-146) both produce predominantly CGRP RNA (Fig. 5, lanes 1 and 6) . Insertion of oligonucleotide AB into these plasmids results in plasmids pRSV dI3E4(35-146)AB and pRSV dI3E4(13-146)AB. After transient transfection of these plasmids, CT-specific RNA is the predominant product (Fig. 5, lanes 5 and 10) . Therefore, decreasing the distance between the 3' splice site and the exon 4 sequence elements, A and B, does not influence the processing choice.
Insertion of either a single element A or a single element B into pRSV dI3E4(13-146) or pRSV dI3E4(35-146) only partially reverses the processing pattern back to CT RNA (Fig.  5, lanes 2 plus 3 and 7 plus 8) . However, insertion of duplicates of element A into pRSV dI3E4(13-146) and duplicates of element B into pRSV dI3E4(35-146) does result in predominantly CT-specific processing (Fig. 5, lane 4 and 9) . Therefore, a double copy of element A or B results in predominantly CT-specific splicing, whereas the presence of a single copy results in the production of both CT RNA and CGRP RNA. This was also observed with the deletion mutants pRSV dI3E4(63-101) and pRSV dI3E4(117-146), in which a single copy of B and a single copy of A are present, respectively.
We conclude that two regions containing specific sequences are required for the splicing of exon 3 to exon 4. The effect of both these sequence elements is additive, since a single copy of either sequence results in the production of approximately equal amounts of CT RNA and CGRP RNA. These sequences are partially redundant and functionally equivalent, because one of them is not necessary when a double copy of the other is present.
The effect of a deletion in exon 4 on the RNA processing choice is dependent on the presence of the authentic branchpoint, and the effect is not limited to the minigene. A uridine VOL. 14, 1994 on residue is used as the major branch acceptor nucleotide in the splicing of exon 3 to exon 4 (3). Mutation of this unusual branchpoint into a more commonly preferred adenosine residue results in an increase of CT RNA production after transient transfection to 293 cells (4) . We tested whether deletion of part of exon 4 still results in the production of CGRP RNA when the branchpoint was mutated to an adenosine residue. In the construct with the deletion from nt 50 to 251 [pRSV dI3E4 ] the uridine branch acceptor nucleotide was mutated to an adenosine, which resulted in plasmid pRSV dI3E4(50-251)U-A. pRSV dI3E4(50-251) was chosen because after transfection of this construct, no CT RNA could be observed (Fig. 6, lane 1) . Therefore, the putative effect of a branchpoint mutation may be most clearly observed with this deletion. As a control, we used plasmid pRSV dI3E4(152-251), which contains a 98-nt deletion but results in the production of CT RNA exclusively (Fig. 6, lane 3) . In this plasmid, we also introduced the U-A branchpoint mutation. The resulting plasmids were transfected to 293 cells, and the results are shown in Fig. 6 . Mutation of the branchpoint in pRSV dI3E4(50-251) causes a switch from CGRP RNA to CT RNA production (Fig. 6,  lanes 1 and 2) . Therefore, the effect of the exon 4 deletion on splice site selection is dependent on the presence of a weak splice acceptor site in front of exon 4. Mutation of the branchpoint in pRSV dI3E4(152-251) also results in an increase in CT-specific processing (Fig. 6, lane 4) .
All deletions in exon 4 we have tested so far were introduced into a minigene which also contained a deletion in intron 3. The intron deletion might have an effect on the processing choice of the exon 4 deletion mutants. To investigate this possibility, the deletion from nt 50 to 251 was introduced into a minigene without intron 3 deletion. As a (Fig. 7, lane 1) , whereas transfection with pRSV dI3E4(152-251) results in the predominant production of CT RNA (Fig. 7, lane 2) . Similar results were obtained with other exon 4 deletion mutants (data not shown).
To exclude the possibility that the effect of the exon 4 deletions on the processing choice is limited to the minigene, the same deletions were introduced in the complete CALC-I gene. After transient transfection of the complete CALC-I gene (pCTS9) to 293 cells, both CT RNA and CGRP RNA could be observed (Fig. 7, lane 3) . Introduction of the deletion in the 5' part of exon 4 [pCTS9dE4(50-251)], however, resulted in the exclusive production of CGRP RNA (Fig. 7, lane 4) . Transfection with pCTS9dE4(152-251) results in a similar CT/CGRP ratio, as observed after transfection with pCTS9 (Fig. 7, lane 5) . Therefore, we conclude that the effect of the deletions in exon 4 on the processing choice is not restricted to the minigene but also occurs with the complete CALC-I gene. CT -__. (23) . The branchpoint mutation also completely abolished the effect of the exon 4 deletion on the processing choice in pRSV dI3E4 . The production of CT RNA after transfection of this mutant suggests that the exon 4 deletions exhibit their effect on 3' splice site selection and not on RNA stability. Mutation of the branchpoint in other constructs (for example, pRSV dI3E4) results in a strong increase in CT-specific processing but not in a complete reversal of the processing pattern (not shown).
DISCUSSION
At the end of exon 4, a weak polyadenylation site is present (59) . According to the exon definition model proposed by Robberson et al. (47) , the presence of a functional poly(A) site or a consensus 5' splice site at the end of an exon stimulates splicing of the preceding intron. However, the effect on the RNA processing of our largest exon 4 deletion (pRSV dI3E4) cannot be suppressed by replacement of the exon 4 poly(A) site with a strong poly(A) site (59) . Replacement of the exon 4 poly(A) site with a strong splice donor site also does not result in a large increase in CTspecific processing (data not shown).
In a model in which the alternative processing of the CALC-I gene is positively regulated, a trans-acting factor would be required to activate the weak exon 4 splice acceptor site. Deletion of exon 4 sequences required for binding of this putative factor results in CGRP-I-specific processing. Reinsertion of the target sequences in different contexts should reverse the splicing pattern. Oligonucleotide AB was inserted into three different deletion mutants in which both sequence elements A and B had been deleted [pRSV dI3E4 , pRSV dI3E4 , and pRSV dI3E4 ]. All three resulting insertion mutants restored CT-specific processing. These results indicate that indeed both elements A and B positively activate CT-specific processing and that their position relative to the exon 4 acceptor site can be varied. Insertion of oligonucleotide A in the negative orientation leads to a small stimulation of CT-specific processing. Insertion of oligonucleotides AB and B in the negative orientation creates a new 3' splice acceptor site within exon 4 because of the presence of 14 consecutive pyrimidine residues. After transfection of these constructs, only splicing of exon 3 to the newly introduced 3' splice site in exon 4 and to exon 5 could be observed. Also, insertion of 4)X DNA fragments does not stimulate CT-specific splicing.
CGRP-I-specific splicing is the predominant reaction, except when cryptic splice sites are present within the inserted (X sequence. CT-specific splicing is only possible when a cryptic donor splice site in the 4)X fragment is already spliced to exon 5 in the same RNA molecule (unpublished data).
The involvement of exon sequences in alternative RNA processing has been shown in many genes, when they act positively or negatively on the processing of that particular pre-mRNA (15, 16, 21, 27, 31, 32, 36, 38, 43, 46, 55, 58, 60, 62 ). An example of a positively regulated gene is the Drosophila doublesex (dsx) pre-mRNA. The structure of this RNA resembles the CALC-I pre-mRNA (10) . In the dsx pre-mRNA, the male-specific splicing of exon 3 to exon 5 is the default choice. Female-specific splicing of exon 3 to exon 4 and polyadenylation at exon 4 requires the presence of the transformer and transforner-2 gene products (10, 33, 34, 42, 44, 50) . The female-specific acceptor site of dsx has a suboptimal polypyrimidine stretch that results in poor recognition of the acceptor site in males (10, 34) . Regulation by tra and tra-2 is the result of activation of the female-specific 3' splice site and is dependent upon a 13-nt repeat, TC(T/ A)(T/A)C(A/G)ATCAACA, which is present six times (10, 33, 34, 43, 50) . The tra and tra-2 proteins are able to bind to this cis regulatory element in exon 4 (33, 35, 57) . Hoshijima et al. (34) examined deletions of different subsets of the six repeats and found that the number of repeats correlated with the efficiency of activation. The presence of only one repeat results in only low amounts of female-specific processing (34, 57) . The presence of two or more copies results predominantly in female-specific processing (33-35, 50, 57) .
In the CALC-I exon 4, we have identified two different sequence elements which cooperate in the activation of CT-specific processing. There is no sequence similarity between these two elements. The presence of only one of these elements results in the production of both CT RNA and CGRP RNA, whereas the presence of both or a double VOL. 14, 1994 on January 4, 2018 by guest http://mcb.asm.org/ 958 VAN OERS ET AL. copy of one of them results in the production of predominantly CT RNA. Therefore, both sequence elements enhance CT-specific splicing in a similar and additive manner. We have looked for sequence similarity between the CALC-I exon 4 sequences and the 13-nt repeat sequence present in the Drosophila doublesex pre-mRNA. There is some sequence similarity between our element A and the dsx repeat (A, ACTTCAACAAGTT, and dsx, TCT'TCAATCAA CA). We have also looked for sequence similarity between our regions and the regulatory exon sequences identified in other pre-mRNAs. There does not seem to be a clear sequence similarity between the different pre-mRNAs. However, the CALC-I exon 4 element B contains a GAA-rich sequence element of 14 consecutive purine residues. In other pre-mRNAs, similar GAA-rich elements which are involved in exon recognition have been identified (16, 27, 32, 38, 62) . If a consensus sequence is involved in the alternative processing of several genes, this might indicate the involvement of the same trans-acting factor. Attractive candidates for this role are the heterogeneous nuclear RNP (hnRNP) proteins. hnRNP proteins have been shown to be associated with the splicing machinery. Immunoprecipitation studies suggest a role for hnRNP C proteins in splicing (13) . hnRNP Al is involved in the selection of 5' splice sites (39) . Binding studies showed that the hnRNP proteins A, C, and D (56) and hnRNP I/PTB (28, 29, 45) bind to the 3' splice site. hnRNPs A, C, D, and I/PTB are part of a larger hnRNP complex, and many of the other proteins in this complex also interact with the RNA in a sequence-dependent manner (6). Bennett et al. (6) suggested that hnRNP proteins play a role in splice site selection, possibly by the selective binding to exon sequences. Binding of these proteins to the pre-mRNA may form a platform for the interaction of other factors. The sequence difference between element A and B suggests that two different factors are involved in the enhancement of CT-specific splicing. Variations in the concentration of these factors in different cells may be responsible for the processing choice, as shown for the ratio of the essential splicing factor ASF/SF2 to hnRNPA1 (39) . Very recently, two papers which showed that the presence of exonic purine-rich elements similar to our element B enhance spliceosome formation and splicing and thereby promote exon inclusion have appeared (63, 64) .
Alternatively, secondary RNA structures present or artificially introduced in pre-mRNAs have been shown to affect splicing in vitro and in vivo (12, 20, 24-26, 52, 53, 61) . For the ,B-tropomyosin pre-mRNA, it has been shown that sequences in the skeletal muscle-specific exon act as negative cis elements which prevent splicing of the skeletal musclespecific exon in myoblasts. At least part of this negative control depends on the existence of a stem-loop structure involving exon sequences (14, 36, 37) . In the alternative processing of the CALC-I gene, local secondary structure might also be involved in the effect we observe after deletion of exon 4 sequences. Deletion of exon 4 sequences might induce a secondary structure which inhibits the splicing of exon 3 to exon 4. We have analyzed the secondary structure of exon 4 and its flanking sequences in the different deletion mutants by using the program of Zuker and Stiegler (65) . This did not reveal a correlation between secondary structure and CT-specific processing. Also, our insertion mutants cover a variety of different constructs, which all induce CT-specific processing. Therefore, the effect of deletion of exon 4 sequences on the RNA processing is predominantly determined by the deletion of specific sequences. The small fluctuation in the CT/CGRP ratio observed after transfection of plasmids containing only element A or B pRSVdI3E4 (117-146) and pRSVdI3E4(87-146) or pRSVdI3E4(63-88), pRSVdI3E4 , and pRSVdI3E4(63-114), respectively, may be caused by subtle changes in the secondary structure of the pre-mRNA.
The identification of two sequence elements A and B within exon 4 which activate CT-specific splicing in nonneural cells and the observation that the U-A branchpoint mutation can overcome the effect of deletion of these sequences on the RNA processing choice suggest a possible way for regulation of the tissue-specific processing of the CALC-I pre-mRNA. Inclusion of the CT-encoding exon 4 in mature RNA in nonneural cells requires, because of the presence of the weak splice acceptor site, initial binding of factors to specific exon 4 sequences to promote CT-specific splicing. Exon skipping leading to CGRP-I mRNA processing in neural cells may be accomplished either by a low concentration of these factors in neural cells or by the presence of a specific dominant neural trans-acting factor which inhibits CT-specific splicing (18, 48) . The presence of a strong acceptor site in front of exon 4 converts the optional exon 4 in a constitutive one, even in neural cells (1, 23) . The production of both CT and CGRP-I mRNA after transfection of the complete CALC-I gene to 293 cells in contrast to predominantly CT RNA synthesis with the minigene indicates that the balance between the two alternative processing pathways is very delicate. As shown in this study, this balance can easily be disturbed by different cis-and probably trans-acting factors. The sequences within the complete CALC-I gene responsible for the stimulation of CGRPspecific splicing in 293 cells may also play a role in the tissue-specific regulation of the alternative splicing.
In conclusion, this study indicates the involvement two separate regions in the 5' end of exon 4 in the selection of the exon 4 3' splice site. It remains to be determined whether these sequences act as target for factors involved in CTspecific processing and whether they are involved in the inhibition of exon 4 splicing in neuronal cells. Further RNA binding studies and mutational analysis of the putative target sequences are needed to answer these questions.
